GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

basiliximab   Click here for help

GtoPdb Ligand ID: 6879

Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®
Approved drug Immunopharmacology Ligand
basiliximab is an approved drug (FDA (1998), EMA (1998))
Compound class: Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: basiliximab

Immunopharmacology Comments
Basiliximab is an anti-IL-2 monoclonal used to prevent organ transplant rejection.
Immunopharmacology Disease
Disease X-Refs Comment References
Allograft rejection Used in combination with other anti-rejection drugs (cyclosporin A, corticosteroids, azathioprine and mycophenolate mofetil) to prevent renal allograft rejection.